Oppenheimer & Co. Inc. Acquires 114,255 Shares of Healthpeak Properties, Inc. $DOC

Oppenheimer & Co. Inc. increased its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 518.5% in the third quarter, Holdings Channel reports. The institutional investor owned 136,291 shares of the real estate investment trust’s stock after buying an additional 114,255 shares during the period. Oppenheimer & Co. Inc.’s holdings in Healthpeak Properties were worth $2,610,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in the stock. Mather Group LLC. bought a new position in Healthpeak Properties during the 3rd quarter worth $25,000. City Holding Co. acquired a new stake in shares of Healthpeak Properties during the 3rd quarter worth $26,000. Sound Income Strategies LLC bought a new position in shares of Healthpeak Properties in the third quarter worth $28,000. Rexford Capital Inc. acquired a new position in Healthpeak Properties in the second quarter valued at about $28,000. Finally, Elevation Point Wealth Partners LLC acquired a new position in Healthpeak Properties in the second quarter valued at about $32,000. 93.57% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on DOC shares. Wells Fargo & Company reiterated a “positive” rating on shares of Healthpeak Properties in a research note on Tuesday, February 3rd. Wall Street Zen upgraded shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. Robert W. Baird lowered their price objective on shares of Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating for the company in a research report on Wednesday, November 12th. Argus cut Healthpeak Properties from a “buy” rating to a “hold” rating in a research note on Thursday, February 5th. Finally, Cantor Fitzgerald set a $17.00 target price on Healthpeak Properties in a report on Monday, January 5th. Six research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $19.42.

Healthpeak Properties Price Performance

DOC stock opened at $16.29 on Friday. The stock has a market cap of $11.32 billion, a price-to-earnings ratio of 162.87, a P/E/G ratio of 9.10 and a beta of 1.12. The company has a debt-to-equity ratio of 1.21, a current ratio of 2.82 and a quick ratio of 2.82. The company has a 50 day simple moving average of $16.79 and a 200 day simple moving average of $17.55. Healthpeak Properties, Inc. has a 1 year low of $15.71 and a 1 year high of $21.28.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, topping analysts’ consensus estimates of $0.45 by $0.02. The firm had revenue of $719.40 million for the quarter, compared to analysts’ expectations of $685.14 million. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The company’s revenue was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. Research analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be issued a $0.1017 dividend. This represents a c) dividend on an annualized basis and a yield of 7.5%. The ex-dividend date of this dividend is Tuesday, March 17th. Healthpeak Properties’s dividend payout ratio is presently 1,220.00%.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.